Source:http://linkedlifedata.com/resource/pubmed/id/19416792
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2009-7-20
|
pubmed:abstractText |
We performed an observational study to investigate if plasma 5-hydroxyindole-3-acetic acid (5-HIAA), a derivative end product of serotonin (5-hydroxytryptamine), concentration could be a predictor for deterioration of urinary albumin excretion. The relationship between baseline plasma 5-HIAA concentration and changes in urinary albumin excretion for 24 months was investigated in 162 male patients with type 2 diabetes mellitus. Patients were divided into tertiles according to plasma 5-HIAA concentration. Greater changes in urinary albumin excretion were seen in patients with high plasma 5-HIAA concentration (112.8 +/- 36.2 mg/g creatinine) than in patients with low plasma 5-HIAA concentration (7.6 +/- 8.0 mg/g creatinine, P = .0011) or in patients with intermediate plasma 5-HIAA concentration (25.6 +/- 15.0 mg/g creatinine, P = .0070) after adjustment for baseline values of urinary albumin excretion. A positive correlation was observed between log (plasma 5-HIAA concentration) and changes in urinary albumin excretion (r = 0.314, P < .0001). Multiple regression analysis demonstrated that log (plasma 5-HIAA concentration) (beta = .284, P = .0013) was an independent determinant of changes in urinary albumin excretion. In conclusion, plasma 5-HIAA concentration was positively correlated with changes in urinary albumin excretion, which may indicate causality in diabetic nephropathy in male patients with type 2 diabetes mellitus and high plasma 5-HIAA concentration.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1532-8600
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1076-9
|
pubmed:meshHeading |
pubmed-meshheading:19416792-Adult,
pubmed-meshheading:19416792-Aged,
pubmed-meshheading:19416792-Albuminuria,
pubmed-meshheading:19416792-Biological Markers,
pubmed-meshheading:19416792-Diabetes Mellitus, Type 2,
pubmed-meshheading:19416792-Diabetic Nephropathies,
pubmed-meshheading:19416792-Humans,
pubmed-meshheading:19416792-Male,
pubmed-meshheading:19416792-Middle Aged,
pubmed-meshheading:19416792-Predictive Value of Tests,
pubmed-meshheading:19416792-Serotonin
|
pubmed:year |
2009
|
pubmed:articleTitle |
Plasma serotonin is a predictor for deterioration of urinary albumin excretion in men with type 2 diabetes mellitus.
|
pubmed:affiliation |
Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kamigyo-ku, Kyoto 602-8566, Japan. sayarinapm@hotmail.com
|
pubmed:publicationType |
Journal Article
|